The Field of Psychopathy Neuroscience Faces a Reputation Issue

The Field of Psychopathy Neuroscience Faces a Reputation Issue

In the realm of neuroscience, the portrayal of psychopathy as a neurodevelopmental disorder has been a widely accepted view, often rooted in the assumption that psychopathy is linked to identifiable brain abnormalities or dysfunctional brain connectivity. This perspective, supported by numerous scientists and backed by structural and functional MRI evidence, has significantly influenced not only academic literature but also its application in the criminal justice system.

However, a recent study by Jarkko Jalava, Stephanie Griffiths, Emma Alcott, and others challenges this mainstream neurodevelopmental portrayal. The research aimed to test if authors of review studies were selectively reporting results that made neuroscientific research on psychopathy appear more robust than it actually is.

In his book "Psychopathy Unmasked", Rasmus Rosenberg Larsen further questions this widespread portrayal. After reviewing three decades of MRI research, Larsen asserts that no reliable or consistent evidence supports the notion that psychopathy—as measured by the Psychopathy Checklist (PCL)—correlates with any brain abnormalities. He emphasizes that the experimental results are mostly null or inconsistent, with observed brain differences often explained better by confounding factors like substance abuse, medication, or head trauma rather than psychopathy itself.

Interestingly, the study found that out of a total of 791 effects across 38 studies, 64.10 percent were null findings. In focused reviews, such as those investigating the effects from the amygdala region, the average null reporting dropped to 2.59 percent. This suggests that the misrepresentation of the empirical evidence in the review literature on psychopathy may be driven, in part, by the phenomenon of scientific spin.

The study also highlighted that between 2000 and 2022, at least 45 review studies were published on MRI neuroimaging evidence and psychopathy, most of which describe the evidence as supportive of the brain-disorder view of psychopathy. However, the authors found that across these studies, authors were on average only reporting 8.99 percent null effects. This discrepancy between the reported findings and the actual results raises concerns about the reliability and validity of the conclusions drawn from the MRI research on psychopathy.

Moreover, the study warns that spin about the brain-disorder view of psychopathy is not limited to the scientific peer-reviewed literature but is arguably more rampant in public media, including op-eds, journalistic interviews, and popular books about psychopathy. This further complicates the issue, as the general public may be misled by these portrayals.

In the courtroom, the use of MRI research on psychopathy has increased in frequency since its first presentation in 2009 in the homicide case State v. Brian Dugan. However, the study concludes that for the past two decades, forensic practitioners and legal decision-makers may have been misled if they had followed due diligence and relied on the review literature when seeking information about neuroimaging research about psychopathy.

The study also suggests more systemic problems with spin, where peer reviewers appear to tolerate the practice. This raises questions about the effectiveness of the peer-review process in ensuring the accuracy and reliability of the research published.

In conclusion, while the neuroimaging research literature often frames psychopathy as a neurodevelopmental brain disorder, Larsen's work argues this is a mischaracterization unsupported by the empirical MRI evidence, which has failed to show clear neurological markers specific to psychopathy. This raises important questions about the use of MRI research in legal proceedings and the need for a more critical and nuanced approach to interpreting and reporting the results of such research.

1. In light of Larsen's book "Psychopathy Unmasked" and Jalava's study, it seems that the portrayal of psychopathy as a neurodevelopmental brain disorder, largely based on MRI evidence, may be questionable, given the findings of many null or inconsistent results.
2. The field of health-and-wellness, particularly mental health, could benefit from a more cautious and critical examination of neuroimaging research on psychopathy, as findings suggest that the neurological markers specific to psychopathy may not be as clear as previously thought.

Read also: